We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
CME Group Rises 5.8% in a Year: How Should You Play the Stock?
Read MoreHide Full Article
Key Takeaways
CME Group's first-half 2026 average daily volume rose 10%, while open interest increased 8%.
Market-data revenues jumped 20% to a record $238 million, marking the eighth consecutive quarterly record.
Product expansion includes crypto trading, extended gold hours, single-stock and planned Compute futures.
Shares of CME Group Inc. (CME - Free Report) have gained 5.8% in the past year against the industry's decline of 9.4%.
CME Group has outperformed its peers, including Intercontinental Exchange Inc. (ICE - Free Report) , S&P Global Inc. (SPGI - Free Report) and Nasdaq, Inc. (NDAQ - Free Report) . Shares of ICE, SPGI and NDAQ have lost 8.5%, 23.8% and 3.6%, respectively, in the past year.
Image Source: Zacks Investment Research
With a market capitalization of $98.9 billion, the average volume of shares traded in the last three months was 2.7 million. CME has a solid track record of beating earnings estimates in three of the last four quarters, and missed in one, with an average of 1.27%.
CME Shares are Overvalued
CME Group shares are trading at a premium to the Zacks Securities and Exchange industry. Its forward price-to-earnings of 21.73X is higher than the industry average of 20.65X.
CME Trading Above 50-Day Moving Averages
Shares of CME Group closed at $275.09 on Tuesday and are trading above the 50-day simple moving average (SMA) of $263.54, indicating solid upward momentum. SMA is a widely used technical analysis tool to predict future price trends by analyzing historical price data.
CME’s Growth Projection
The Zacks Consensus Estimate for CME Group’s 2026 earnings per share (EPS) indicates a 9.5% year-over-year increase. The consensus estimate for revenues is pegged at $7.03 billion, implying a year-over-year improvement of 7.8%.
The consensus estimate for 2027 EPS and revenues indicates an increase of 4.8% and 4.8%, respectively, from the corresponding 2026 estimates.
Optimistic Analyst Sentiment for CME
Nine of the 11 analysts covering the stock have raised estimates for 2026, and eight analysts have raised the same for 2027 over the past 60 days. Thus, the Zacks Consensus Estimate for 2025 and 2026 earnings has moved up 0.8% and 0.7%, respectively, in the past 60 days.
Target Price Reflects Potential Upside
Based on short-term price targets offered by 15 analysts, the Zacks average price target is $284.40 per share. The average indicates a potential 1.4% upside from the last closing price.
Image Source: Zacks Investment Research
Factors Impacting CME
CME Group continues to strengthen its position as a leading global derivatives marketplace, supported by strong trading activity, product expansion and a scalable operating model. In the first half of 2026, average daily volume (ADV) rose 10% year over year, while open interest increased 8% from the prior-year period to 127 million contracts. More than $95 billion of average daily margin efficiencies in the second quarter further enhanced the value of its integrated clearing platform.
The company’s electronic operating model also supports revenue scalability.
CME is simultaneously broadening its addressable market. New initiatives include continuous cryptocurrency trading, extended gold trading hours, single-stock futures and the planned launch of Compute futures. Treasury Link, expected in the fourth quarter of 2026, is designed to connect Treasury futures with cash-market liquidity.
Market data represents another increasingly important growth engine. Second-quarter market-data and information-services revenues jumped 20% year over year to a record $238 million, marking the eighth consecutive quarterly record. Continued demand for proprietary pricing and benchmark data could support this relatively recurring revenue stream amid ongoing market uncertainty and rising adoption of algorithmic and AI-driven analytics.
CME also maintains significant financial flexibility. As of June 30, 2026, it had approximately $2.3 billion in cash and $3.4 billion of debt. During the second quarter, CME paid $468 million in regular dividends and repurchased $695 million of shares. Its combination of volume-driven growth, expanding market-data revenues, product innovation and capital returns provides multiple avenues for sustaining shareholder value.
End Notes
CME Group continues to benefit from strong trading activity, product expansion and a scalable business model. Growth in market-data revenues provides a recurring revenue stream, supported by demand for financial information and analytics.
Meanwhile, new products and extended trading hours broaden its addressable markets. Strong cash generation also supports dividends and share repurchases.
View the Zacks #1 Rank List
Image: Shutterstock
CME Group Rises 5.8% in a Year: How Should You Play the Stock?
Key Takeaways
Shares of CME Group Inc. (CME - Free Report) have gained 5.8% in the past year against the industry's decline of 9.4%.
CME Group has outperformed its peers, including Intercontinental Exchange Inc. (ICE - Free Report) , S&P Global Inc. (SPGI - Free Report) and Nasdaq, Inc. (NDAQ - Free Report) . Shares of ICE, SPGI and NDAQ have lost 8.5%, 23.8% and 3.6%, respectively, in the past year.
Image Source: Zacks Investment Research
With a market capitalization of $98.9 billion, the average volume of shares traded in the last three months was 2.7 million. CME has a solid track record of beating earnings estimates in three of the last four quarters, and missed in one, with an average of 1.27%.
CME Shares are Overvalued
CME Group shares are trading at a premium to the Zacks Securities and Exchange industry. Its forward price-to-earnings of 21.73X is higher than the industry average of 20.65X.
CME Trading Above 50-Day Moving Averages
Shares of CME Group closed at $275.09 on Tuesday and are trading above the 50-day simple moving average (SMA) of $263.54, indicating solid upward momentum. SMA is a widely used technical analysis tool to predict future price trends by analyzing historical price data.
CME’s Growth Projection
The Zacks Consensus Estimate for CME Group’s 2026 earnings per share (EPS) indicates a 9.5% year-over-year increase. The consensus estimate for revenues is pegged at $7.03 billion, implying a year-over-year improvement of 7.8%.
The consensus estimate for 2027 EPS and revenues indicates an increase of 4.8% and 4.8%, respectively, from the corresponding 2026 estimates.
Optimistic Analyst Sentiment for CME
Nine of the 11 analysts covering the stock have raised estimates for 2026, and eight analysts have raised the same for 2027 over the past 60 days. Thus, the Zacks Consensus Estimate for 2025 and 2026 earnings has moved up 0.8% and 0.7%, respectively, in the past 60 days.
Target Price Reflects Potential Upside
Based on short-term price targets offered by 15 analysts, the Zacks average price target is $284.40 per share. The average indicates a potential 1.4% upside from the last closing price.
Image Source: Zacks Investment Research
Factors Impacting CME
CME Group continues to strengthen its position as a leading global derivatives marketplace, supported by strong trading activity, product expansion and a scalable operating model. In the first half of 2026, average daily volume (ADV) rose 10% year over year, while open interest increased 8% from the prior-year period to 127 million contracts. More than $95 billion of average daily margin efficiencies in the second quarter further enhanced the value of its integrated clearing platform.
The company’s electronic operating model also supports revenue scalability.
CME is simultaneously broadening its addressable market. New initiatives include continuous cryptocurrency trading, extended gold trading hours, single-stock futures and the planned launch of Compute futures. Treasury Link, expected in the fourth quarter of 2026, is designed to connect Treasury futures with cash-market liquidity.
Market data represents another increasingly important growth engine. Second-quarter market-data and information-services revenues jumped 20% year over year to a record $238 million, marking the eighth consecutive quarterly record. Continued demand for proprietary pricing and benchmark data could support this relatively recurring revenue stream amid ongoing market uncertainty and rising adoption of algorithmic and AI-driven analytics.
CME also maintains significant financial flexibility. As of June 30, 2026, it had approximately $2.3 billion in cash and $3.4 billion of debt.
During the second quarter, CME paid $468 million in regular dividends and repurchased $695 million of shares. Its combination of volume-driven growth, expanding market-data revenues, product innovation and capital returns provides multiple avenues for sustaining shareholder value.
End Notes
CME Group continues to benefit from strong trading activity, product expansion and a scalable business model. Growth in market-data revenues provides a recurring revenue stream, supported by demand for financial information and analytics.
Meanwhile, new products and extended trading hours broaden its addressable markets. Strong cash generation also supports dividends and share repurchases.
Its solid growth projection and positive analyst statements are other positives. The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.